Oxalic acid dihydrate → 3-[2-[4-(2-Chloro-10,11-dihydro-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone

HRID 435724ノート

反応式

HRID 435724 の反応式
[Cl:1][C:2]1[CH:30]=[CH:29][C:5]2[S:6][C:7]3[CH:28]=[CH:27][CH:26]=[CH:25][C:8]=3[C:9]([N:11]3[CH2:16][CH2:15][N:14]([CH2:17][CH2:18][N:19]4[CH2:23][CH2:22][O:21][C:20]4=[O:24])[CH2:13][CH2:12]3)=[CH:10][C:4]=2[CH:3]=1.[BH4-].[Na+].O.O.C(O)(=O)C(O)=O>COCCOCCOC>[Cl:1][C:2]1[CH:30]=[CH:29][C:5]2[S:6][C:7]3[CH:28]=[CH:27][CH:26]=[CH:25][C:8]=3[CH:9]([N:11]3[CH2:12][CH2:13][N:14]([CH2:17][CH2:18][N:19]4[CH2:23][CH2:22][O:21][C:20]4=[O:24])[CH2:15][CH2:16]3)[CH2:10][C:4]=2[CH:3]=1

参加物

5

反応物 3

HCID 61373Oxalic acid dihydrateHCID 4311764Sodium borohydrideHCID 214560453-[2-[4-(2-Chloro-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone

生成物 1

HCID 214811413-[2-[4-(2-Chloro-10,11-dihydro-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone

試薬・触媒・溶媒 1

HCID 8150Diglyme溶媒2 回

反応条件

温度
100 °C

実験手順

750 mg of 3-[2-[4-(2-chloro-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone, 0.6 g of sodium borohydride and 30 ml of diglyme are treated dropwise under an argon atmosphere at 20°-30° C over a period of 15 minutes with 2.7 g of oxalic acid dihydrate in 15 ml of diglyme. The mixture is heated for 4 hours at an internal temperature of 100° C and subsequently evaporated under reduced pressure. The residue is treated with chloroform and 2-N sodium hydroxide solution. After equilibration, the aqueous phase is separated and washed twice with chloroform. The combined chloroform extracts are washed with water, dried over potassium carbonate and active carbon, filtered and evaporated under reduced pressure. There is obtained 3-[2-[4-(2-chloro-10,11-dihydro-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone in the form of a brown oil. The maleate of melting point 173°-175° C is prepared by treatment with maleic acid in ethanol/ether.

後処理

  1. customsubsequently evaporated under reduced pressure
  2. additionThe residue is treated with chloroform and 2-N sodium hydroxide solution
  3. customAfter equilibration, the aqueous phase is separated
  4. washwashed twice with chloroform
  5. washThe combined chloroform extracts are washed with water
  6. dry with materialdried over potassium carbonate and active carbon
  7. filtrationfiltered
  8. customevaporated under reduced pressure

出典と根拠

ORDレコード
ord-2db3ff3144d143a19b85f40c0efbfb36
出典データセット
uspto-grants-1977_02
特許番号
US04006144

反応ノート

読み込み中…